The head of the Laboratory of Clinical Pharmacology and Therapeutics at the University of Lisbon gave his perspective on the importance of the study population of this analysis.
Joaquim Ferreira, MD, PhD
Advertisement
Articles by Joaquim Ferreira, MD, PhD
The head of the Laboratory of Clinical Pharmacology and Therapeutics at the University of Lisbon gave his perspective on the importance of the study population of this analysis.
Advertisement
Latest Updated Articles
Joaquim Ferreira, MD, PhD: Opicapone’s Use in Levodopa-Treated Patients With Parkinson DiseasePublished: September 16th 2020 | Updated:
Joaquim Ferreira, MD, PhD: The Magnitude of Effect for Opicapone in Parkinson DiseasePublished: October 1st 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Early Results Show Symptom Gains in First Patient Dosed With UX-DA001 Cell Therapy for Parkinson Disease
2
Using Brain Stimulation to Curb Cannabis Overuse in Multiple Sclerosis
3
Understanding Key Clinical and Genetic Biomarkers in Huntington Disease Research: Sarah O'Shea, MD, MSc
4
Testing D1 Receptor Modulator Glovadalen in Phase 2 Trial for Parkinson Disease: Milton Biagioni MD, CMD
5
